This issue of the Bankruptcy Update focuses on recent restructurings in the pharmaceutical industry, including Aralez Pharmaceuticals, Egalet Corporation and Synergy Pharmaceuticals.

‘Aralez Pharmaceuticals US’

On Aug. 10, 2018, specialty pharmaceutical company Aralez Pharmaceuticals US and its affiliates filed petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of New York. Aralez Pharmaceuticals US (Bankr. S.D.N.Y. Case No. 18-12426).